Background-We have recently found that administration of L-arginine to hype
rcholesterolemic rabbits induces regression of preexisting lesions. Others
have previously shown that activation of the L-arginine/nitric oxide (NO) s
ynthase pathway can induce apoptosis of vascular cells in vitro. Accordingl
y, the current study was designed to determine if dietary supplementation o
f L-arginine induces apoptosis of intimal lesions and if this effect is med
iated through the NO synthase pathway.
Methods and Results-Male New Zealand White rabbits were fed a 0.5% choleste
rol diet for 10 weeks and subsequently placed on 2.5% L-arginine HCl in the
drinking water, and the cholesterol diet was continued for 2 weeks, at whi
ch time the aortas were harvested for histological studies. L-Arginine trea
tment increased the number of apoptotic cells (largely macrophages) in the
intimal lesions by 3-fold (11.9+/-3.9 vs 3.9+/-1.4 apoptotic cells/mm(2), P
<0.01). In subsequent studies, aortas were harvested for ex vivo studies. A
ortic segments were incubated in cell culture medium for 4 to 24 hours with
modulators of the NO synthase pathway. The tissues were then collected for
histological studies and the conditioned medium collected for measurement
of nitrogen oxides by chemiluminescence. Addition of sodium nitroprusside (
10(-5) mol/L) to the medium caused a time-dependent increase in apoptosis o
f vascular cells (largely macrophages) in the intimal lesion. L-Arginine (1
0(-3) mol/L) had an identical effect on apoptosis, which was associated wit
h an increase in nitrogen oxides released into the medium. These effects we
re not mimicked by D-arginine, and they were antagonized by the NO synthase
inhibitor L-nitro-arginine (10(-4) mol/L), The effect of L-arginine was no
t influenced by an antagonist of cGMP-dependent protein kinase, nor was the
effect mimicked by the agonist of protein kinase G or 8-BR cGMP,
Conclusions-These results indicate that supplemental L-arginine induces apo
ptosis of macrophages in intimal lesions by its metabolism to NO, which act
s through a cGMP-independent pathway. These studies are consistent with our
previous observation that supplementation of dietary arginine induces regr
ession of atheroma in this animal model. These studies provide a rationale
for further investigation of the therapeutic potential of manipulating the
NO synthase pathway in atherosclerosis.